FIS vs INM · P/E 7.9, rev $6.67B vs rev $4.9M
Fidelity National Information Services Inc (FIS) versus InMed Pharmaceuticals Inc (INM) — a side-by-side from cached financials, not a winner call.
Fidelity National Information Services Inc (FIS) is a information technology services company listed on US.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported FIS revenue for 2026-06-30 was $6.67B. Net income was $2.60B. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
FIS currently screens at market cap $21.12B and trailing P/E 7.9. INM currently screens at market cap $5.2M.
Not investment advice. Open the FIS and INM stock pages for the full models.
Not investment advice.